An observational study in Arterial Hypertension, sponsored by University Hospital, Strasbourg, France. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-02-26.
Sponsored by University Hospital, Strasbourg, France · Observational
Norepinephrine is the vasopressor of choice for the treatment of peri-anesthetic arterial hypotension. The use of this drug at significantly lower concentrations (dilution factor between 40 and 200) than the commercial preparation is increasingly common in the operating room ("baby-noradrenaline").
In addition, dilution errors are potentially serious for the patient (hypertensive peak) The preparation of precise dilutions is an important factor for the safe use of this medically In this study, the investigators wish to compare the dilution method of the protocol with another method of preparation (left to the free choice of the participant).
6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.
This study's planned enrollment of 50 is below the median of 210 across 1,359 observational studies indexed under Hypertension.
Browse Hypertension studies →University Hospital, Strasbourg, France is the lead sponsor of 966 studies on the registry; 342 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Employee of the University Hospitals of Strasbourg accepting to participate in the study
Exclusion criteria:
Measurement of noradrenaline concentrations using different dilution methods
Measurement methods: * High performance liquid chromatography * Measurement of the concentration of noradrenaline in the biochemical laboratory of the University Hospitals of Strasbourg
Time frame: 1 hour after the preparation of the noradrenaline solutions
This study is status unknown, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Strasbourg, France